From: Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation
Characteristics | Low risk group | High risk group | ||||
---|---|---|---|---|---|---|
Short interval | Long interval | P | Short interval | Long interval | P | |
Patients | 65 | 25 | Â | 79 | 21 | Â |
Relapse location (%) | Â | Â | 0.868 | Â | Â | 0.383 |
 Local | 26 (40.6) | 11 (44.0) |  | 29 (37.2) | 5 (23.8) |  |
 Intrahepatic distant | 37 (57.8) | 14 (56.0) |  | 47 (60.3) | 15 (71.4) |  |
 Extrahepatic | 1.0 (1.6) | 0.0 (0.0) |  | 2 (2.6) | 1 (4.8) |  |
Intrahepatic tumor number | 1.0 (1.0) | 1.5 (1.0) | 0.811 | 1.0 (1.0) | 2.0 (1.0) | 0.229 |
Intrahepatic tumor size (cm) | 1.7 (1.5) | 1.9 (1.9) | 0.718 | 1.9 (1.5) | 1.6 (1.3) | 0.797 |
Curative intent (%) | 44.0 (77.2) | 18.0 (81.8) | 0.886 | 43 (64.2) | 6 (37.5) | 0.087 |
BCLC (%) | Â | Â | 0.172 | Â | Â | 0.028 |
 0 | 19 (29.2) | 6 (24.0) |  | 15 (19.0) | 2 (9.5) |  |
 A | 35 (53.8) | 12 (48.0) |  | 46 (58.2) | 10 (47.6) |  |
 B | 7 (10.8) | 5 (20.0) |  | 8 (10.1) | 3 (14.3) |  |
 C & D | 4 (6.2) | 2 (8.0) |  | 10 (12.7) | 6 (28.6) |  |